# Nurigra Chewable Tablet in Healthy Adult Male Volunteers

> **NCT01651858** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 52 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nurigra Chewable tablet

## Key facts

- **NCT ID:** NCT01651858
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** —
- **Final completion:** 2012-03
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2012-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651858, "Nurigra Chewable Tablet in Healthy Adult Male Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01651858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*